Reviewed by Emily Henderson, B.Sc.Jun 17 2020 A new test developed at CHU Sainte-Justine in Montreal will enable better management of patients with severe combined immunodeficiency (SCID). The results of this work was presented Tuesday in the medical journal Blood Advances published by the American Society of Hematology. Routine neonatal screening, although not yet available